Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK.

Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK.

<h4>Objectives</h4> <p>To characterise the costs to the UK National Health Service of cardiovascular (CV) events among individuals receiving lipid-modifying therapy.</p> <h4>Design</h4> <p>Retrospective cohort study using Clinical Practice Research Datalink...

Full description

Bibliographic Details
Main Authors:	Danese, MD, Gleeson, M, Kutikova, L, Griffiths, RI, Azough, A, Khunti, K, Seshasai, SRK, Ray, KK
Format:	Journal article
Language:	English
Published:	BMJ Publishing Group 2016

Similar Items

Economic burden of cardiovascular events and fractures among patients with end-stage renal disease.
by: Doan, Q, et al.
Published: (2007)

Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
by: Griffiths, R, et al.
Published: (2010)

Second-line therapy in diffuse large B-cell lymphoma (DLBCL): treatment patterns and outcomes in older patients receiving outpatient chemotherapy.
by: Danese, MD, et al.
Published: (2016)

TRENDS IN THE BURDEN OF CARDIOVASCULAR DISEASES IN THE UK, 1961 TO 2011
by: Bhatnagar, P, et al.
Published: (2011)

Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors
by: María Torrente, et al.
Published: (2022-12-01)

The Burden of Cardiovascular Disease Attributable to Major Modifiable Risk Factors in Indonesia
by: Mohammad Akhtar Hussain
Published: (2016-10-01)

Uncovering the treatable burden of severe aortic stenosis in the UK
by: Simon Stewart, et al.
Published: (2022-01-01)

Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare.
by: Griffiths, R, et al.
Published: (2012)

Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare.
by: Griffiths, R, et al.
Published: (2012)

Impact of undetected comorbidity on treatment and outcomes of breast cancer.
by: Griffiths, R, et al.
Published: (2014)

Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
by: Griffiths, R, et al.
Published: (2010)

Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
by: Gleeson Michelle, et al.
Published: (2010-11-01)

Coronary plaque burden predicts perioperative cardiovascular events after coronary endarterectomy
by: Mingxin Gao, et al.
Published: (2023-06-01)

Quantifying Societal Burden of Radiation-Induced Cardiovascular Events in Breast Cancer Survivors
by: Eva Kimpe, et al.
Published: (2022-04-01)

Prediction models for individual-level healthcare costs associated with cardiovascular events in the UK
by: Zhou, J, et al.
Published: (2023)

Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events
by: Bansilal Sameer, et al.
Published: (2009-04-01)

The impact of addressing modifiable risk factors to reduce the burden of cardiovascular disease in Turkey
by: Yücel Balbay, et al.
Published: (2019-09-01)

Joint effect of modifying selected risk factors on attributable burden of Cardiovascular Diseases
by: Fatemeh Khosravi Shadmani, et al.
Published: (2013-01-01)

Choosing lipid lowering statin in risk strategy of cardiovascular event prevention
by: A. Ya. Yvleva, et al.
Published: (2007-02-01)

Inverse probability weighted least squares regression in the analysis of time-censored cost data: an evaluation of the approach using SEER-Medicare.
by: Griffiths, R, et al.
Published: (2012)

Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease
by: Ana Palanca, et al.
Published: (2019-07-01)

Cardiovascular risk burden, dementia risk and brain structural imaging markers: a study from UK Biobank
by: Ting Li, et al.
Published: (2024-02-01)

Modelling the burden of cardiovascular disease in Saudi Arabia and the impact of reducing modifiable risk factors
by: Isabelle Gagnon-Arpin, et al.
Published: (2018-10-01)

Infused therapy and survival in older patients diagnosed with metastatic breast cancer who received trastuzumab.
by: Griffiths, R, et al.
Published: (2011)

1239 Major adverse cardiovascular events (MACE) in patients with melanoma receiving immune checkpoint inhibitors
by: Bo Zhao, et al.
Published: (2023-11-01)

Effects of iron-based phosphate binders on mortality and cardiovascular events in patients receiving maintenance dialysis
by: Akihito Tanaka, et al.
Published: (2023-09-01)

Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID study
by: Simes John, et al.
Published: (2010-04-01)

Progression of coronary atherosclerotic plaque burden and relationship with adverse cardiovascular event in asymptomatic diabetic patients
by: Junjie Yang, et al.
Published: (2019-02-01)

Coronary artery calcification, epicardial fat burden, and cardiovascular events in chronic obstructive pulmonary disease.
by: Thomas Gaisl, et al.
Published: (2015-01-01)

Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma.
by: Griffiths, R, et al.
Published: (2011)

Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma
by: Griffiths, R, et al.
Published: (2012)

Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma.
by: Griffiths, R, et al.
Published: (2012)

Identification of an increased lifetime risk of major adverse cardiovascular events in UK Biobank participants with scoliosis
by: James S Ware, et al.
Published: (2023-02-01)

Preparation and use of monoclonal antibodies to detect Phytophthora nicotianae var. nicotianae
by: Blanka Pekárová-Kyněrová, et al.
Published: (1999-06-01)

Cardiovascular risk profiles and the uptake of the NHS Healthcheck programme in male prisoners in six UK prisons: an observational cross-sectional survey
by: Kamlesh Khunti, et al.
Published: (2020-05-01)

Hesitancy for receiving regular SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis from the UK-REACH study
by: Neyme Veli, et al.
Published: (2022-10-01)

Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis.
by: Nissenson, A, et al.
Published: (2005)

P783: CLINICAL, HUMANISTIC, AND ECONOMIC BURDEN IN PATIENTS WITH PNH RECEIVING C5 INHIBITION TREATMENT ACROSS UK, GERMANY, AND FRANCE. INSIGHTS FROM THE COMMODORE BURDEN OF ILLNESS STUDY
by: Louis Terriou, et al.
Published: (2023-08-01)

The economic burden of coronary heart disease in the UK.
by: Liu, J, et al.
Published: (2002)

The burden of food related ill health in the UK.
by: Rayner, M, et al.
Published: (2005)